Low-dose rosuvastatin for hypercholesterolemic patients with the metabolic syndrome
Hannah Camm
This article has no abstract so we have provided the first paragraph of the full text.
While statin therapy is an obvious part of combined drug treatment for the optimum management of combined hyperlipidemia, the efficacy of statin therapy, and a comparison of the effects of different statins, have not been investigated in patients with the metabolic syndrome.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Solar size variationNature News and Views (31 Jul 1980)
Mal-function of TLRs by SOCSNature Immunology News and Views (01 Feb 2006)
